Microbiome and Heart Failure: A Comprehensive Review of Gut Health and Microbiota-Derived Metabolites in Heart Failure Progression
Medical Sciences · 2025
DOI: 10.3390/medsci13040302 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Medical Sciences, 2025. Verfasst von Chukwudi Kingsley Orjichukwu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Well Health Manitoba Clinic, 790 Sherbrook Street, Winnipeg MB R3A 1M4, Canada. Hauptthemen laut MEDLINE: Heart Failure, Gastrointestinal Microbiome. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 117 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Herzinsuffizienz
Abstract (Originalsprache)
A multifaceted clinical disease, heart failure (HF) is typified by decreased cardiac function and systemic symptoms caused by anatomical or functional abnormalities in the heart. Although traditional studies have concentrated on hemodynamic and neurohormonal processes, new data highlight the vital role that the gut microbiota and its byproducts play in the pathogenesis of HF. An imbalance in the microbial structure known as gut dysbiosis is common in HF patients and is linked to increased gut permeability, systemic inflammation, and changed bioactive metabolite synthesis. Prominent metabolites generated by the microbiota, including phenylacetylglutamine, short-chain fatty acids (SCFAs), secondary bile acids, and trimethylamine N-oxide (TMAO), have a major impact on endothelial function, cardiac remodeling, and inflammation. Together with gut-derived lipopolysaccharides, these metabolites interact with host systems to exacerbate the course of HF. Further impacting HF outcomes are comorbidities such as diabetes, obesity, and chronic renal disease, which intensify gut dysbiosis. The importance of metabolites originating from the microbiota in the progression of HF is highlighted in this review, which summarizes recent findings regarding the gut-heart axis. Additionally, it investigates how dietary changes, probiotics, prebiotics, and multi-omics techniques can all be used to improve the management of HF. This thorough analysis emphasizes the necessity of integrative therapy approaches and longitudinal research to better address the complex link between HF and the gut microbiota.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Well Health Manitoba Clinic, 790 Sherbrook Street, Winnipeg MB R3A 1M4, Canada.
- Medway Maritime Hospital, Gillingham ME7 5NY, UK.
- North London NHS Foundation Trust, IT Department, 3rd Floor, West Wing, St. Pancras Hospital, 4 St. Pancras Way, London NW1 0PE, UK.
- King George Hospital, Barley Lane, Ilford IG3 8YB, UK.
- Cranfield University, Central Ave., Cranfield, Bedford MK43 0AL, UK.
- University of Wolverhampton, Wulfruna Street, Wolverhampton, West Midlands WV1 1LY, UK.
ORCID-Profile: Somtochukwu Godfrey Nnabuife
Zitieren
APA
Orjichukwu, C. K., Orjichukwu, R. O., Akpunonu, P. K., Ugwu, P. C., & Nnabuife, S. G. (2025). Microbiome and Heart Failure: A Comprehensive Review of Gut Health and Microbiota-Derived Metabolites in Heart Failure Progression. Medical Sciences. https://doi.org/10.3390/medsci13040302
Vancouver
Orjichukwu CK, Orjichukwu RO, Akpunonu PK, Ugwu PC, Nnabuife SG. Microbiome and Heart Failure: A Comprehensive Review of Gut Health and Microbiota-Derived Metabolites in Heart Failure Progression. Medical Sciences. 2025. doi:10.3390/medsci13040302
BibTeX
@article{Orjichukwu2025,
author = {Orjichukwu, Chukwudi Kingsley and Orjichukwu, Rita Ogochukwu and Akpunonu, Peter Kanayochukwu and Ugwu, Paul Chikwado and Nnabuife, Somtochukwu Godfrey},
title = {Microbiome and Heart Failure: A Comprehensive Review of Gut Health and Microbiota-Derived Metabolites in Heart Failure Progression},
journal = {Medical Sciences},
year = {2025},
doi = {10.3390/medsci13040302}
}
EUVIMED